Basics |
Cerus Corporation
Cerus Corp is a biomedical products company. It is engaged in developing and commercializing the INTERCEPT Blood System to enhance blood safety.
|
IPO Date: |
January 31, 1997 |
Sector: |
Healthcare |
Industry: |
Health Care Equipment and Supplies |
Market Cap: |
$246.6M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.12 | 2.74%
|
Avg Daily Range (30 D): |
$0.05 | 3.32%
|
Avg Daily Range (90 D): |
$0.05 | 3.24%
|
Institutional Daily Volume |
Avg Daily Volume: |
.74M |
Avg Daily Volume (30 D): |
1.23M |
Avg Daily Volume (90 D): |
1.28M |
Trade Size |
Avg Trade Size (Sh.): |
178 |
Avg Trade Size (Sh.) (30 D): |
213 |
Avg Trade Size (Sh.) (90 D): |
213 |
Institutional Trades |
Total Inst.Trades: |
941 |
Avg Inst. Trade: |
$1.28M |
Avg Inst. Trade (30 D): |
$1.09M |
Avg Inst. Trade (90 D): |
$1.13M |
Avg Inst. Trade Volume: |
.24M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$1.27M |
Avg Closing Trade (30 D): |
$.93M |
Avg Closing Trade (90 D): |
$1.08M |
Avg Closing Volume: |
225.79K |
|
|
|
|
Financials |
|
TTM |
Q4 2024 |
FY 2024 |
Basic EPS
|
$-.11
|
$-.01
|
$-.11
|
Diluted EPS
|
$-.11
|
$-.01
|
$-.11
|
Revenue
|
$ 201.32M
|
$ 114.08M
|
$ 201.32M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -20.96M
|
$ -2.56M
|
$ -20.96M
|
Operating Income / Loss
|
$ -14.23M
|
$ -1.45M
|
$ -14.23M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ 8M
|
$ -1.85M
|
$ 8M
|
PE Ratio
|
|
|
|
|